Occurrence, prevalence and genetic environment of CTX-M β-lactamases in Enterobacteriaceae from Indian hospitals—authors' response

Microbiol Infect Dis 2002; 44: 367–77. 3. Jones RN, Rhomberg PR, Varnam DJ et al. A comparison of the antimicrobial activity of meropenem and selected broad-spectrum antimicrobials tested against multi-drug resistant Gram-negative bacilli including bacteraemic Salmonella spp.: initial studies for the MYSTIC programme in India. Int J Antimicrob Agents 2002; 20: 426–31. 4. Toleman MA, Beidenbach D, Jones RN et al. Molecular characterisation of b-lactamases from Escherichia coli isolated from a multicentre trial in India: benchmark report from the MYSTIC program. In: Abstracts of the Forty-second Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, 2002. Abstract C2-1872, p. 114. American Society for Microbiology, Washington, DC, USA. 5. Karim A, Poirel L, Nagarajan S et al. Plasmid-mediated extendedspectrum b-lactamase (CTX-M3-like) from India and association with insertion sequence IS Ecp1. FEMS Microbiol Lett 2001; 201: 237–41. 6. Lartigue M-F, Poirel L, Nordmann P. Diversity of genetic environment of blaCTX-M genes. FEMS Microbiol Lett 2004; 234: 201–7.